Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis.
about
Vascular Glucose Sensor Symposium: Continuous Glucose Monitoring Systems (CGMS) for Hospitalized and Ambulatory Patients at Risk for Hyperglycemia, Hypoglycemia, and Glycemic VariabilityThe future is now: software-guided intensive insulin therapy in the critically illThe effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysisThe benefits of tight glycemic control in critical illness: Sweeter than assumed?Management of critically ill patients with type 2 diabetes: The need for personalised therapyDiabetes and the Association of Postoperative Hyperglycemia With Clinical and Economic Outcomes in Cardiac Surgery.A Comparison of Inpatient Cost Per Day in General Surgery Patients with Type 2 Diabetes Treated with Basal-Bolus versus Sliding Scale Insulin RegimensGlucose control in intensive care: usability, efficacy and safety of Space GlucoseControl in two medical European intensive care unitsPrevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgeryAlterations in insulin-signaling and coagulation pathways in platelets during hyperglycemia-hyperinsulinemia in healthy non-diabetic subject.Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS.Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies.Inpatient Management of Diabetes Mellitus among Noncritically Ill Patients at University Hospital of Puerto Rico.Association of time in blood glucose range with outcomes following cardiac surgery.Relationship between glycemic control and readmission rates in patients hospitalized with congestive heart failure during implementation of hospital-wide initiatives.Diagonal earlobe crease and coronary artery disease in a Chinese population.Effect of diabetes mellitus on outcomes of hyperglycemia in a mixed medical surgical intensive care unit.Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study.Year in review 2009: Critical Care--metabolism.Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes.Hypoglycemia revisited in the acute care setting.GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes.In patients with acute myocardial infarction, the impact of hyperglycemia as a risk factor for mortality is not homogeneous across age-groups.Elevated admission glucose and mortality in patients with acute pulmonary embolism.Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adultsAccuracy of a novel noninvasive transdermal continuous glucose monitor in critically ill patients.Intensive control of diabetes in the hospital: why, how, and what is in the future?Mild hypoglycemia is strongly associated with increased intensive care unit length of stay.Hyperglycemia in Critically Ill Patients: Management and Prognosis.Persistent hyperglycemia modulates gut immune function and microbiota in rats.Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized PatientsUse of an Intravascular Fluorescent Continuous Glucose Sensor in ICU Patients.In-hospital death in acute coronary syndrome was related to admission glucose in men but not in women.Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial.Mild hypoglycemia is independently associated with increased mortality in the critically ill.Novel approach to inpatient glucometric monitoring and variability in a community hospital settingEstablishment and Validation of GV-SAPS II Scoring System for Non-Diabetic Critically Ill Patients.Usefulness of Glycemic Gap to Predict ICU Mortality in Critically Ill Patients With DiabetesComparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes.Glycemic Variation in Tumor Patients with Total Parenteral Nutrition.
P2860
Q26852360-6C64F892-8C56-4460-983A-D7AED96452C8Q26864579-F07B1970-3A43-4B9D-B53D-4C659F5867BBQ27028133-FB498806-7824-4FA3-9551-2BB92481C0CFQ28081397-7FF72A60-B940-4EEF-B76C-891593ED6F5EQ28081465-29F7C2A6-3C88-4FE7-8CCD-7CCE91DCD267Q30277717-5152BA3F-7B61-4EFF-B356-496D43921CD6Q33788963-3B12186C-CD45-4C97-9BB6-56A140B00F46Q33987913-2344C9DE-3B3E-4BEC-AFD1-BF41BEC26EF7Q34016041-CBC0E02B-6ACA-4D13-BDF8-4E6F080C2CB7Q34104492-4E37C020-5411-48F1-9624-638C0FF34425Q34130693-A0E97803-B251-49A1-BD5D-D7E4B8CA1AE5Q34418911-3EA30DF3-C08B-4EC5-B70E-CF3753476CFEQ34751777-82087D27-EAF0-42EA-ACB9-C43E41D5F7F0Q35068888-56B2EFA1-B6E8-4050-8BC2-9D2B987B338BQ35126000-26662002-E321-4DC3-95D7-B75DFD57EBD4Q35141204-B877899D-96F1-4AF0-BE47-A20EEDBC7501Q35337724-28865097-E3FB-4E84-9CB3-D967751338C9Q35561210-4A8E6072-A66A-48CF-B0A0-FBFD5C2B5103Q35561361-CB594A14-7465-4717-8495-C81B63374C47Q35561368-8BC7986E-67FC-4522-95AC-EAE8118FBEEFQ35561860-2C5D7BF5-F4C8-4BF7-A901-BBD01B9D1DC0Q35587378-36EFDF6C-CDF2-48C9-AA98-BD6F32AC8BE5Q35620181-51EED0D2-1D77-4658-89AE-CF6DA9B6CDA8Q35620243-280E6E27-F47C-44F8-998F-BA0FE15066BFQ35658934-798FE38A-3F70-4625-9E0D-66481E06E9B2Q35682640-08761E25-4111-4E79-BE81-C0A66DB6B5EBQ35685021-1C6AE080-A1FB-4702-9421-BA23D901E6B2Q35739742-DD0EA5A3-3FDC-4C05-901C-A7DBBD6C0638Q35846237-E4165C9B-FEAE-4C5A-893D-65D552E6EDBDQ35881062-E3494DE4-3B6D-43D3-A044-1ADE25C830F8Q35912987-4F9C3C4D-A995-4E41-AE62-53748F8CEEA4Q35918434-F2C2D809-E9B6-4F3D-A965-831ED2DE8A84Q35968424-28B4566B-54F1-4B11-9B98-D48DE30713E5Q35973242-A1E004C4-148A-4C23-9EE7-7E1AAD4A2976Q36070438-8DA495DC-8AE2-4ED5-A789-0A575ABC9D17Q36159133-AC474BE1-329A-49FD-89D2-35225CD24491Q36185812-4D4112F5-670D-4AC1-8305-BF52B6247A96Q36194918-D5FAF59F-5D52-4B24-B008-5069515BF913Q36311661-46C4F77A-EE43-4544-9623-2AF901FFE864Q36477188-EB20C3BC-8739-44F4-8157-CAB623A62249
P2860
Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hyperglycemia-related mortalit ...... ries with admission diagnosis.
@ast
Hyperglycemia-related mortalit ...... ries with admission diagnosis.
@en
Hyperglycemia-related mortalit ...... ries with admission diagnosis.
@nl
type
label
Hyperglycemia-related mortalit ...... ries with admission diagnosis.
@ast
Hyperglycemia-related mortalit ...... ries with admission diagnosis.
@en
Hyperglycemia-related mortalit ...... ries with admission diagnosis.
@nl
prefLabel
Hyperglycemia-related mortalit ...... ries with admission diagnosis.
@ast
Hyperglycemia-related mortalit ...... ries with admission diagnosis.
@en
Hyperglycemia-related mortalit ...... ries with admission diagnosis.
@nl
P2093
P2860
P1476
Hyperglycemia-related mortalit ...... ries with admission diagnosis.
@en
P2093
David A D'Alessio
Marta L Render
Mercedes Falciglia
Peter L Almenoff
Ron W Freyberg
P2860
P304
P356
10.1097/CCM.0B013E3181B083F7
P407
P577
2009-12-01T00:00:00Z